Your browser is no longer supported. Please, upgrade your browser.
NRBO NeuroBo Pharmaceuticals, Inc. daily Stock Chart
NeuroBo Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-24.19 Insider Own19.40% Shs Outstand0.60M Perf Week-24.00%
Market Cap10.72M Forward P/E- EPS next Y-1.28 Insider Trans0.00% Shs Float0.21M Perf Month118.07%
Income-13.80M PEG- EPS next Q-0.20 Inst Own59.90% Short Float8.67% Perf Quarter99.65%
Sales- P/S- EPS this Y47.00% Inst Trans228.52% Short Ratio0.79 Perf Half Y25.33%
Book/sh-1.80 P/B- EPS next Y-16.40% ROA-173.10% Target Price30.00 Perf Year-38.41%
Cash/sh3.17 P/C5.64 EPS next 5Y- ROE-419.70% 52W Range5.95 - 37.13 Perf YTD104.11%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-51.89% Beta3.59
Dividend %- Quick Ratio0.70 Sales past 5Y- Gross Margin- 52W Low200.17% ATR3.31
Employees9 Current Ratio0.70 Sales Q/Q- Oper. Margin- RSI (14)57.45 Volatility17.07% 23.68%
OptionableNo Debt/Eq- EPS Q/Q43.60% Profit Margin- Rel Volume0.63 Prev Close18.18
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume23.45K Price17.86
Recom1.00 SMA2029.19% SMA5074.81% SMA20025.41% Volume14,793 Change-1.76%
Jan-13-20 09:00AM  NeuroBo Pharmaceuticals to Present at Biotech Showcase 2020 in San Francisco Business Wire -9.40%
Jan-10-20 05:00PM  NeuroBo Pharmaceuticals and Gemphire Therapeutics Complete Merger Business Wire
NeuroBo Pharmaceuticals, Inc. provides novel therapies for diabetic neuropathic pain and central nervous system diseases. NeuroBo Pharmaceuticals, Inc. was founded in 2017 and is based in Boston, Massachusetts.